A world-first study led by Austin Health's clinician-researchers has demonstrated the feasibility and safety of using ...

Radiotherapy professionals from 10 Asian countries have completed an IAEA training course on ultra-hypofractionated radiotherapy — a way of treating cancer with ionizing radiation that reduces ...

The patients received Lutetium (177Lu) rhPSMA-10.1 Injections at both St Bartholomew's Hospital, London, and The James Cook University Hospital, Middlesbrough -- Lutetium (177Lu) rhPSMA-10.1 Injection ...

IAEA radiation oncologist Soha Salem leading a session on ultra-hypofractionated radiotherapy during a regional training course held in Malaysia in ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC programmeThe patients received Lutetium (177Lu) rhPSMA-10.1 Injections at ...

Purpose-built facility secures Convergent’s drug product manufacturing at the scale needed to meet late-stage CONV01-α ...

Profound Medical Corp. ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased ...

ISMI offers a radiologist-led Full-Body MRI in Montreal to identify life-saving findings, detect health risks, and support ...

In a significant move aimed at strengthening regulatory clarity for cancer related medical technologies, the Central Drugs ...

New York City-based Brigade Capital Management increased its LNTH holding by 173,200 shares in the third quarter. The move contributed to a net position value increase of about $4.51 million. As of ...